OR WAIT null SECS
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
Cytiva’s new facility in Shrewsbury, MA will make equipment such as single-use bioreactors.
Cytiva opened its new 80,000-ft2 manufacturing facility in Shrewsbury, MA, the company announced in a Dec. 21, 2020 press release. The new facility will make Xcellerex XDR single-use bioreactors and is part of Cytiva’s $500 million global capacity expansion planned for the next five years. The Shrewsbury site expansion was supported by a Technology Investment Agreement entered in October with the Biomedical Advanced Research and Development Authority (BARDA).
The new facility was built in less than five months to meet demand for the company’s technologies. The building includes five manufacturing lines operating 24/5, a new cleanroom, and an R&D lab. The company is also adding manufacturing lines for complementary single-use technologies at its Westborough, MA facility and expects the capacity expansion to be completed by Q2 2021.